Protagenic Therapeutics- Warrants (13/04/2025) P/E Ratio

The latest P/E ratio for PTIXW is 0.27. That is below the Industrials sector average of 31.57. Investors often review this figure alongside Protagenic Therapeutics- Warrants (13/04/2025)'s historical trend and sector peers before judging valuation or financial health.

Against Industrials companies, PTIXW currently prints 0.27 for P/E ratio, while the sector average sits near 31.57. That is roughly 99.1% below the sector mean. Large gaps often invite a closer look at Protagenic Therapeutics- Warrants (13/04/2025)'s growth, margins, and balance sheet.

A P/E ratio of 0.27 for Protagenic Therapeutics- Warrants (13/04/2025) is not 'good' or 'bad' on its own. Compare it with the peer average (31.57) and with PTIXW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting PTIXW's P/E ratio (0.27), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Protagenic Therapeutics- Warrants (13/04/2025)'s P/E ratio against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.